|
Apr 12
|
Bank earnings, housing, Trump trial: What to Watch Next Week
|
|
Apr 12
|
3 Quarterly Releases to Watch Next Week
|
|
Apr 12
|
J&J (JNJ) to Begin Pharma Q1 Earnings Season: What's in Store?
|
|
Apr 12
|
5 Dividend Kings That Yield More Than Vanguard's Top Value ETF
|
|
Apr 11
|
UPDATE 1-Kenya recalls J&J children's cough syrup over suspected toxicity
|
|
Apr 11
|
Kenya recalls J&J children's cough syrup over suspected toxicity
|
|
Apr 11
|
Unlocking Q1 Potential of Johnson & Johnson (JNJ): Exploring Wall Street Estimates for Key Metrics
|
|
Apr 10
|
J&J, Rallybio partner on drug development for rare fetal condition
|
|
Apr 10
|
The Pharmaceutical Industry Finds Itself At A Historical Crossroads
|
|
Apr 10
|
Nigeria recalls J&J children's cough syrup over toxic substance
|
|
Apr 10
|
What's in Store for Dow ETFs in Q1 Earnings?
|
|
Apr 10
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
|
Apr 10
|
Johnson & Johnson (NYSE:JNJ) Seems To Use Debt Quite Sensibly
|
|
Apr 10
|
Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
|
|
Apr 9
|
Neutrogena Closing Its Los Angeles Headquarters to Move to New Jersey
|
|
Apr 9
|
Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 9
|
How's AT&T Handling Things?
|
|
Apr 9
|
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
|
|
Apr 8
|
Here's Why Johnson & Johnson (JNJ) Fell More Than Broader Market
|
|
Apr 8
|
Kenvue Revamps Cyber Tools After Spinoff From J&J
|